Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Evolution and progression of Barrett's oesophagus to oesophageal cancer
S Killcoyne, RC Fitzgerald - Nature Reviews Cancer, 2021 - nature.com
Cancer cells are shaped through an evolutionary process of DNA mutation, cell selection
and population expansion. Early steps in this process are driven by a set of mutated driver …
and population expansion. Early steps in this process are driven by a set of mutated driver …
Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus
The incidence of adenocarcinoma of the esophagus has been increasing in develo**
countries over the last three decades and probably reflects a genuine increase in the …
countries over the last three decades and probably reflects a genuine increase in the …
Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma
Esophageal cancer ranks sixth in cancer death. To explore its genetic origins, we conducted
exomic sequencing on 11 esophageal adenocarcinomas (EAC) and 12 esophageal …
exomic sequencing on 11 esophageal adenocarcinomas (EAC) and 12 esophageal …
Evolution of neoplastic cell lineages in Barrett oesophagus
MT Barrett, CA Sanchez, LJ Prevo, DJ Wong… - Nature …, 1999 - nature.com
It has been hypothesized that neoplastic progression develops as a consequence of an
acquired genetic instability and the subsequent evolution of clonal populations with …
acquired genetic instability and the subsequent evolution of clonal populations with …
Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma
K Kawakami, J Brabender, RV Lord… - Journal of the …, 2000 - academic.oup.com
Background: The adenomatous polyposis coli (APC) locus on chromosome 5q21–22 shows
frequent loss of heterozygosity (LOH) in esophageal carcinomas. However, the prevalence …
frequent loss of heterozygosity (LOH) in esophageal carcinomas. However, the prevalence …
Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression
BJ Reid, LJ Prevo, PC Galipeau… - Official journal of the …, 2001 - journals.lww.com
OBJECTIVES: Most patients with Barrett's esophagus do not progress to cancer, but those
who do seem to have markedly increased survival when cancers are detected at an early …
who do seem to have markedly increased survival when cancers are detected at an early …
Multiple mutation analyses in single tumor cells with improved whole genome amplification
W Dietmaier, A Hartmann, S Wallinger… - The American journal of …, 1999 - Elsevier
Combining whole genome amplification (WGA) methods with novel laser-based
microdissection techniques has made it possible to exploit recent progress in molecular …
microdissection techniques has made it possible to exploit recent progress in molecular …
Quantitative real-time PCR: a powerful ally in cancer research
S Mocellin, CR Rossi, P Pilati, D Nitti… - Trends in molecular …, 2003 - cell.com
In this era of the Human Genome Project, quantitation of gene expression in tumor or host
cells is of paramount importance for investigating the gene patterns responsible for cancer …
cells is of paramount importance for investigating the gene patterns responsible for cancer …
A framework for adaptive MCMC targeting multimodal distributions
E Pompe, C Holmes, K Łatuszyński - 2020 - projecteuclid.org
Supplement to “A framework for adaptive MCMC targeting multimodal distributions”. In
Supplementary Material A we present the proofs of our theoretical results of Section 3 and …
Supplementary Material A we present the proofs of our theoretical results of Section 3 and …
Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett's esophagus
Neoplastic progression is an evolutionary process characterized by genomic instability and
waves of clonal expansions carrying genetic and epigenetic lesions to fixation (100% of the …
waves of clonal expansions carrying genetic and epigenetic lesions to fixation (100% of the …